The FDA let one 79-year-old take an experimental obesity drug. That sure sounds like the president, but let’s examine the evidence.

A stunning report reveals the president may have gotten an early access to an obesity drug to treat major medical issues.

A bombshell report about how a 79-year-old man got early access to a weight loss drug has all eyes on the president.

Compassionate use of retatrutide granted for someone with sleep apnea, pulmonary hypertension